Estats Units - anglès - NLM (National Library of Medicine)

cardinal health - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20) - sodium bicarbonate 0.2 g in 5 ml - neut (4% sodium bicarbonate additive solution) is indicated for use as an additive to raise the ph of acid solutions administered intravenously to reduce the incidence of chemical phlebitis and patient discomfort due to vein irritation at or near the site of infusion. not for use as a systemic alkalizer. none known.

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

morningside healthcare ltd - vancomycin hydrochloride - oral capsule - 125mg

Estats Units - anglès - NLM (National Library of Medicine)

cardinal health - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20) - neut (4% sodium bicarbonate additive solution) is indicated for use as an additive to raise the ph of acid solutions administered intravenously to reduce the incidence of chemical phlebitis and patient discomfort due to vein irritation at or near the site of infusion. not for use as a systemic alkalizer. none known.

Estats Units - anglès - NLM (National Library of Medicine)

hospira, inc. - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20, sodium cation - unii:lyr4m0nh37) - neut (4% sodium bicarbonate additive solution) is indicated for use as an additive to raise the ph of acid solutions administered intravenously to reduce the incidence of chemical phlebitis and patient discomfort due to vein irritation at or near the site of infusion. not for use as a systemic alkalizer. none known.

Estats Units - anglès - NLM (National Library of Medicine)

ani pharmaceuticals, inc. - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin 125 mg - vancomycin hydrochloride capsules are indicated for the treatment of clostridioides difficile -associated diarrhea. vancomycin hydrochloride capsules are also used for the treatment of enterocolitis caused by staphylococcus aureus (including methicillin-resistant strains) in adult and pediatric patients less than 18 years of age. limitations of use to reduce the development of drug-resistant bacteria and maintain the effectiveness of vancomycin hydrochloride capsules and other antibacterial drugs, vancomycin hydrochloride capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. vancomycin hydrochloride capsules are contraindicated in patients with known hypersensitivity

Canadà - anglès - Health Canada

fresenius kabi canada ltd - vancomycin (vancomycin hydrochloride) - capsule - 125mg - vancomycin (vancomycin hydrochloride) 125mg - glycopeptides

Canadà - anglès - Health Canada

fresenius kabi canada ltd - vancomycin (vancomycin hydrochloride) - capsule - 250mg - vancomycin (vancomycin hydrochloride) 250mg - glycopeptides

Canadà - anglès - Health Canada

pharmascience inc - vancomycin (vancomycin hydrochloride) - capsule - 125mg - vancomycin (vancomycin hydrochloride) 125mg - glycopeptides

Canadà - anglès - Health Canada

pharmascience inc - vancomycin (vancomycin hydrochloride) - capsule - 250mg - vancomycin (vancomycin hydrochloride) 250mg - glycopeptides

Canadà - anglès - Health Canada

jamp pharma corporation - vancomycin (vancomycin hydrochloride) - capsule - 125mg - vancomycin (vancomycin hydrochloride) 125mg - glycopeptides